Expand AERI Menu
AERI MENU

About AERI

Aerie is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie recently reported the successful results of its second Phase 3 registration trial in the United States named Rocket 2, where the primary efficacy endpoint was to demonstrate non-inferiority of IOP lowering for Rhopressa compared to timolol. Rocket 3, a 12-month safety-only study, is currently in progress, and Aerie has recently commenced a fourth Phase 3 trial for Rhopressa, named Rocket 4. Aerie also completed in 2014 a Phase 2b clinical trial in which Roclatan met the primary efficacy endpoint, demonstrating the statistical superiority of Roclatan to each of its components, and recently commenced the first Phase 3 registration trial for Roclatan, named Mercury 1. Aerie also recently announced research collaborations with GrayBug, Inc. and Ramot at Tel Aviv University as it further builds its pipeline for future growth.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Biological Product (except Diagnostic) Manufacturing

AERI is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
UBIO Proshares UltraPro Nasdaq Biotechnology 26.9 M 2.68812E+07 221 221 0.03% 0.00029379 26 K 25651
URTY ProShares UltraPro Russell2000 99.2 M 9.92442E+07 2,003 2003 0.01% 0.000113202 36 K 35906
UWM ProShares Ultra Russell2000 219.8 M 2.19791E+08 2,003 2003 0.02% 0.000195226 90 K 89778
FAD First Trust Multi Cap Growth AlphaDEX Fund 188.8 M 1.88774E+08 675 675 0.05% 0.0005 93 K 92799
FYC First Trust Small Cap Growth AlphaDEX Fund 234.1 M 2.34142E+08 263 263 0.25% 0.0025 579 K 579098
FYX First Trust Small Cap Core AlphaDEX Fund 574.9 M 5.74854E+08 526 526 0.06% 0.0006 359 K 359480
VB Vanguard Small-Cap ETF 27.4 B 2.74E+10 1,359 1359 0.03% 0.000288736 8.2 M 8194570
VBR Vanguard Small-Cap Value ETF 14.8 B 1.48E+10 852 852 0.05% 0.000524683 7.9 M 7895250
VHT Vanguard Health Care ETF 10.0 B 1E+10 394 394 0.02% 0.000233814 2.3 M 2347140
VTWG Vanguard Russell 2000 Growth ETF 342.7 M 3.427E+08 1,175 1175 0.09% 0.000914079 324 K 324085
SCHA Schwab U.S. Small-Cap ETF 9.3 B 9.3283E+09 1,753 1753 0.03% 0.0003 3.1 M 3058144
SCHB Schwab U.S. Broad Market ETF 16.8 B 1.67852E+10 2,477 2477 0.0% 0 475 K 475380
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.5 B 1.48129E+09 2,223 2223 0.01% 5.1E-05 74 K 74459
IBB iShares Nasdaq Biotechnology Index Fund 7.7 B 7.65081E+09 215 215 0.13% 0.0013 9.6 M 9550850
IHE iShares U.S. Pharmaceutical ETF 362.4 M 3.62389E+08 45 45 0.36% 0.0036 1.3 M 1314400
ITOT iShares Core S&P Total U.S. Stock Market ETF 25.9 B 2.58526E+10 3,675 3675 0.0% 0 735 K 735207
IWM iShares Russell 2000 ETF 48.0 B 4.80197E+10 1,992 1992 0.05% 0.0005 21.4 M 2.13602E+07
IWO iShares Russell 2000 Growth ETF 10.2 B 1.02471E+10 1,167 1167 0.09% 0.0009 8.9 M 8894590
IWV iShares Russell 3000 ETF 10.5 B 1.0517E+10 2,885 2885 0.0% 0 323 K 322999
BIB ProShares Ultra Nasdaq Biotechnology 179.3 M 1.79276E+08 226 226 0.05% 0.00049022 190 K 190288
IEIH iShares Evolved U.S. Innovative Healthcare ETF 5.7 M 5710610 232 232 0.07% 0.0007 4 K 4093
HDGE Ranger Equity Bear Bear ETF 109.2 M 1.09233E+08 60 60 -0.02% -0.000156 -1.7 M -1705500
XPH SPDR S&P Pharmaceuticals ETF 234.7 M 2.3465E+08 42 42 3.11% 0.0311359 7.4 M 7378697
FHLC Fidelity MSCI Health Care Index ETF 1.8 B 1.8E+09 364 364 0.02% 0.00023377 419 K 419008
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.1 B 2.1E+09 1,002 1002 0.02% 0.000185257 389 K 389394
VTWO Vanguard Russell 2000 ETF 1.6 B 1.6E+09 2,002 2002 0.05% 0.000473421 775 K 775083